Litchfield Hills Research Starts Mateon Therapeutics (MATN) at Buy
Tweet Send to a Friend
Litchfield Hills Research analyst Theodore O'Neill initiates coverage on Mateon Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
